Advertisement

Topics

FDA guidances on NGS Dx tests for germline diseases draw industry comments

06:49 EDT 18 Oct 2016 | SmartBrief

The FDA's draft guidances on next-generation sequencing-based diagnostic technologies for germline diseases have been lauded  -More

Original Article: FDA guidances on NGS Dx tests for germline diseases draw industry comments

NEXT ARTICLE

More From BioPortfolio on "FDA guidances on NGS Dx tests for germline diseases draw industry comments"

Quick Search
Advertisement
 

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...